Latest Breaking News On - Chun hsien tsai - Page 1 : vimarsana.com

Ainos Announces $1 75 Million Follow-On Funding

Ainos Announces $1 75 Million Follow-On Funding
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoUnited kingdomRobin yangMaxim groupAinos incSecurities exchangeTaiwan inabata sangyo coLind global fundArcadia securitiesNisshinbo micro devices incNisshinbo micro devicesTaiwan inabata sangyoLind partnersChun hsien tsaiSenior secured convertible promissory note

Ainos (AIMD) Receives $1 75M Follow-On Funding

Ainos (AIMD) Receives $1 75M Follow-On Funding
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ainos incLind global fundArcadia securitiesMaxim groupLind partnersChun hsien tsaiSenior secured convertible promissory noteCapital markets

Ainos : PROMISSORY NOTE EXTENSION AGREEMENT - Form 8-K -Today at 09:56 am

PROMISSORY NOTE EXTENSION AGREEMENT This Promissory Note Agreement is entered into this 17th day of August, 2023 by and between Ainos, Inc., a Texas corporation , and i2China.

United statesLawrence linChina management groupAinos incPromissory note agreementManagement groupNon convertible promissory notePrincipal amountEffective dateChun hsien tsaiHsien tsai

Ainos Appoints Amanda Sung as New Chief Financial Officer

17.05.2023 - Current CFO Celia Wu announces her retirement and transition to consulting roleSung brings nearly two decades of public company audit and compliance experience with major international accounting firmsSAN DIEGO, CA / ACCESSWIRE / May 17, 2023 / . Seite 1

United statesSercomm corporationErnst youngChun hsien tsaiAino chairmanChief executive officerChief financialVice president

Ainos Submits Investigational New Drug Application to the U S FDA to Conduct Phase 2 Trial of its VELDONA Low-dose Oral Interferon Formulation Against Mild COVID-19 Symptoms

Ainos Submits Investigational New Drug Application to the U S FDA to Conduct Phase 2 Trial of its VELDONA Low-dose Oral Interferon Formulation Against Mild COVID-19 Symptoms
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRobin yangExchange commissionAinos incCompany phaseWorld health organizationDrug administrationOur companyInvestigational new drugChun hsien tsaiVolatile organic compoundsSecurities litigation reform actAnnual reportUnited states wire group